Regulation of matrix metalloproteinases (MMPs) expression and secretion in MDA-MB-231 breast cancer cells by LIM and SH3 protein 1 (LASP1)

被引:44
|
作者
Endres, Marcel [1 ]
Kneitz, Susanne [2 ]
Orth, Martin F. [1 ]
Perera, Ruwan K. [1 ]
Zernecke, Alma [1 ]
Butt, Elke [1 ]
机构
[1] Univ Med Clin Wuerzburg, Inst Expt Biomed 2, Wurzburg, Germany
[2] Univ Wurzburg, Physiol Chem, Biozentrum, Wurzburg, Germany
关键词
LASP1; matrix metalloproteinases; c-Fos; AP-1; extracellular matrix; HEPATOCELLULAR-CARCINOMA CELLS; COLORECTAL-CANCER; DOMAIN PROTEIN-1; EPITHELIAL-CELLS; PROSTATE-CANCER; ACTIN-BINDING; INVASION; PROLIFERATION; MIGRATION; PODOSOMES;
D O I
10.18632/oncotarget.11720
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The process of tumor invasion requires degradation of extracellular matrix by proteolytic enzymes. Cancer cells form protrusive invadopodia, which produce and release matrix metalloproteinases (MMPs) to degrade the basement membrane thereby enabling metastasis. We investigated the effect of LASP1, a newly identified protein in invadopodia, on expression, secretion and activation of MMPs in invasive breast tumor cell lines. By analyzing microarray data of in-house generated control and LASP1-depleted MDA-MB-231 breast cancer cells, we observed downregulation of MMP1, -3 and -9 upon LASP1 depletion. This was confirmed by Western blot analysis. Conversely, rescue experiments restored in part MMP expression and secretion. The regulatory effect of LASP1 on MMP expression was also observed in BT-20 breast cancer cells as well as in prostate and bladder cancer cell lines. In line with bioinformatic FunRich analysis of our data, which mapped a high regulation of transcription factors by LASP1, public microarray data analysis detected a correlation between high LASP1 expression and enhanced c-Fos levels, a protein that is part of the transcription factor AP-1 and known to regulate MMP expression. Compatibly, in luciferase reporter assays, AP-1 showed a decreased transcriptional activity after LASP1 knockdown. Zymography assays and Western blot analysis revealed an additional promotion of MMP secretion into the extracellular matrix by LASP1, thus, most likely, altering the microenvironment during cancer progression. The newly identified role of LASP1 in regulating matrix degradation by affecting MMP transcription and secretion elucidated the migratory potential of LASP1 overexpressing aggressive tumor cells in earlier studies.
引用
收藏
页码:64244 / 64259
页数:16
相关论文
共 50 条
  • [1] An update on the LIM and SH3 domain protein 1 (LASP1): a versatile structural, signaling, and biomarker protein
    Orth, Martin F.
    Cazes, Alex
    Butt, Elke
    Grunewald, Thomas G. P.
    ONCOTARGET, 2015, 6 (01) : 26 - 42
  • [2] Role of LIM and SH3 Protein 1 (LASP1) in the Metastatic Dissemination of Medulloblastoma
    Traenka, Christopher
    Remke, Marc
    Korshunov, Andrey
    Bender, Sebastian
    Hielscher, Thomas
    Northcott, Paul A.
    Witt, Hendrik
    Ryzhova, Marina
    Felsberg, Joerg
    Benner, Axel
    Riester, Stephanie
    Scheurlen, Wolfram
    Grunewald, Thomas G. P.
    von Deimling, Andreas
    Kulozik, Andreas E.
    Reifenberger, Guido
    Taylor, Michael D.
    Lichter, Peter
    Butt, Elke
    Pfister, Stefan M.
    CANCER RESEARCH, 2010, 70 (20) : 8003 - 8014
  • [3] LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma
    Wang, Bei
    Feng, Ping
    Xiao, Ziwei
    Ren, Ee-Chee
    JOURNAL OF HEPATOLOGY, 2009, 50 (03) : 528 - 537
  • [4] Crocetin Inhibits Invasiveness of MDA-MB-231 Breast Cancer Cells via Downregulation of Matrix Metalloproteinases
    Chryssanthi, Dimitra G.
    Dedes, Petros G.
    Karamanos, Nikos K.
    Cordopatis, Paul
    Lamari, Fotini N.
    PLANTA MEDICA, 2011, 77 (02) : 146 - 151
  • [5] LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas
    Vanderheijden, Cas
    Vaessen, Thomas
    Yakkioui, Youssef
    Riedl, Robert
    Temel, Yasin
    Hovinga, Koos
    Hoogland, Govert
    JOURNAL OF NEURO-ONCOLOGY, 2022, 158 (01) : 81 - 88
  • [6] Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion
    Gao, Wei
    Han, Jiakai
    ONCOLOGY RESEARCH, 2017, 25 (06) : 879 - 886
  • [7] Suppression of LIM and SH3 Domain Protein 1 (LASP1) Negatively Regulated by Androgen Receptor Delays Castration Resistant Prostate Cancer Progression
    Dejima, Takashi
    Imada, Kenjiro
    Takeuchi, Ario
    Shiota, Masaki
    Leong, Jeffrey
    Tombe, Tabitha
    Tam, Kevin
    Fazli, Ladan
    Naito, Seiji
    Gleave, Martin E.
    Ong, Christopher J.
    PROSTATE, 2017, 77 (03) : 309 - 320
  • [8] LIM and SH3 protein 1 (LASP1) differentiates malignant chordomas from less malignant chondrosarcomas
    Cas Vanderheijden
    Thomas Vaessen
    Youssef Yakkioui
    Robert Riedl
    Yasin Temel
    Koos Hovinga
    Govert Hoogland
    Journal of Neuro-Oncology, 2022, 158 : 81 - 88
  • [9] The role of LIM and SH3 protein-1 in bladder cancer metastasis
    Sato, Misaki
    Yoneyama, Mihoko Sutoh
    Hatakeyama, Shingo
    Funyu, Tomihisa
    Suzuki, Tadashi
    Ohyama, Chikara
    Tsuboi, Shigeru
    ONCOLOGY LETTERS, 2017, 14 (04) : 4829 - 4834
  • [10] Role of hepatitis B virus X protein in regulating LIM and SH3 protein 1 (LASP-1) expression to mediate proliferation and migration of hepatoma cells
    Renxian Tang
    Fanyun Kong
    Lina Hu
    Hongjuan You
    Peng Zhang
    Weidong Du
    Kuiyang Zheng
    Virology Journal, 9